Cure My Disease

Don't miss your cure!

 Log in / Sign up

Five-Minute Finger-Prick test could speed syphilis diagnosis in pregnancy

NCT ID NCT06829602

Recruiting now Diagnosis Sponsor: McMaster University Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests whether a rapid finger-prick blood test for syphilis and HIV can be used in a prenatal clinic for pregnant people at risk. The test gives results in five minutes, potentially speeding up diagnosis and treatment. Participants will provide feedback on their experience, and researchers will measure how often the test is accepted and how well it works in practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Rapid Syphilis/HIV point-of-care test (INSTI Multiplex HIV/Syphilis Duo Antibody Test)
What this could lead to
If successful, this rapid test could help prevent syphilis complications in pregnancy by enabling faster diagnosis and treatment in high-risk settings.
What could go wrong
This is a small feasibility study, so results may not apply broadly. The test may not be widely adopted or may not significantly improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYPHILIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

syphilis congenital syphilis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYPHILIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maternity Centre of Hamilton

    RECRUITING

    Hamilton, Ontario, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.